Sky Century Investment (SKYI) Cash & Equivalents (2012 - 2026)
Sky Century Investment's (SKYI) quarterly Cash & Equivalents came in at $264.0 in Q2 2026, down 97.67% year-on-year from $11312.0 in Q2 2025, and down 92.14% on a QoQ basis from $3360.0 in Q1 2026.
Sky Century Investment (SKYI) Cash & Equivalents (2012 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has 5 years of Cash & Equivalents data on file, last reported at $264.0 in Q2 2026.
- On a quarterly basis, Cash & Equivalents fell 97.67% year-over-year to $264.0 in Q2 2026; TTM through May 2026 was $264.0, a 97.67% decrease from a year earlier, with the FY2025 full-year figure at $477.0, changed N/A from the prior year.
- Cash & Equivalents for Q2 2026 stood at $264.0, down from $3360.0 in the prior quarter.
- Over the last five years, Cash & Equivalents for SKYI reached as high as $11312.0 in Q2 2025 and fell as low as $264.0 in Q2 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - | 1.76 Bn |
| 2 | Teva Pharmaceutical Industries | 35.84 Bn | 32.10 Bn | 1.97 Bn | 3.74 Bn |
| 3 | Zoetis | 32.67 Bn | 30.73 Bn | 1.62 Bn | 1.94 Bn |
| 4 | Takeda Pharmaceutical | 27.69 Bn | 23.63 Bn | 4.39 Bn | 3.79 Bn |
| 5 | United Therapeutics | 23.12 Bn | 20.97 Bn | 648.10 Mn | 1.28 Bn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | 3.97 Mn |
| 7 | Viatris | 20.24 Bn | 18.44 Bn | 1.16 Bn | 1.80 Bn |
| 8 | Neurocrine Biosciences | 17.83 Bn | 16.51 Bn | 800.70 Mn | 266.50 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.22 Bn | 785.00 Mn | 428.00 Mn |
| 10 | Sky Century Investment | 1.06 Mn | 1.06 Mn | 26,045.00 | 264.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 264.00 |
| Feb 28, 2026 | 3,360.00 |
| Nov 30, 2025 | 467.00 |
| Aug 31, 2025 | 477.00 |
| May 31, 2025 | 11,312.00 |
| Aug 31, 2014 | 515.00 |
| May 31, 2014 | 515.00 |
| Feb 28, 2014 | 515.00 |
| Nov 30, 2013 | 5,565.00 |
| Aug 31, 2013 | 479.00 |
| May 31, 2013 | 154.00 |
| Feb 28, 2013 | 154.00 |
| Aug 31, 2012 | 854.00 |